References
1. Eckel HE, Bradley PJ. Natural History of Treated and Untreated Hypopharyngeal Cancer. Adv Otorhinolaryngol . 2019; 27-34. doi:10.1159/000492305
2. Chandrasekharappa SC, Chinn SB, Donovan FX, et al. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. Cancer . 2017;123(20):3943–3954. doi:10.1002/cncr.30802
3. Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN, et al. A Rare Truncating BRCA2 Variant and Genetic Susceptibility to Upper Aerodigestive Tract Cancer. J Natl Cancer Inst . 2015;107(5). doi:10.1093/jnci/djv037
4. Kemp SRM-D, Brink A, Meulen IHVD, et al. The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics. Mol Cancer Ther . 2016;16(3):540-550. doi:10.1158/1535-7163.mct-16-0457
5. Wattenberg, M.M., Asch, D., Yu, S. et al.  Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2  or PALB2  mutation. Br J Cancer  122,  333–339 (2020). https://doi.org/10.1038/s41416-019-0582-7
Figure 1: T2 weighted axial MRI image of tumor invading right thyroid cartilage and encasing right carotid.
Figure 2: Right piriform sinus mass extending to right pharyngeal wall with minimal medial disruption in appearance of glottic and supraglottic structures.